Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Hansen

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
BMC Cancer|May 25, 2019
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancerHanna Abrahamsson, Alina C Porojnicu, Jonas C Lindstrøm, et al.
Clinical & Experimental Metastasis|March 19, 2009
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profilingAse Bratland, Piet J Boender, Hanne K Høifødt, et al.
Immunotargets and Therapy|May 20, 2026
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial DataSebastian Meltzer, Silje Sjåvik Landmark, Jūratė Šaltytė Benth, et al.
Circulation|May 17, 2021
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and MetoprololSiri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree, et al.
Translational Oncology|October 2, 2018
Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal CancerPaula A Bousquet, Sebastian Meltzer, Linda Sønstevold, et al.
Plos One|April 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitroMarion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, et al.
Cancer Research and Treatment|August 5, 2016
Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic RadiotherapyErta Kalanxhi, Karianne Risberg, Imon S Barua, et al.
BMC Pediatrics|November 14, 2018
A retrospective study of neonatal case management and outcomes in rural Rwanda post implementation of a national neonatal care package for sick and small infantsMerab Nyishime, Ryan Borg, Willy Ingabire, et al.
Clinical Simulation in Nursing|March 21, 2022
A Multimodal Approach to Training Coronavirus Disease (COVID-19) Processes Across Four Intensive Care UnitsKatie M Moynihan, Dorothy M Beke, Annette Imprescia, et al.
European Heart Journal. Cardiovascular Imaging|November 7, 2017
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trialSiri Lagethon Heck, Geeta Gulati, Pavel Hoffmann, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
BMC Cancer|May 25, 2019
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancerHanna Abrahamsson, Alina C Porojnicu, Jonas C Lindstrøm, et al.
Clinical & Experimental Metastasis|March 19, 2009
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profilingAse Bratland, Piet J Boender, Hanne K Høifødt, et al.
Immunotargets and Therapy|May 20, 2026
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial DataSebastian Meltzer, Silje Sjåvik Landmark, Jūratė Šaltytė Benth, et al.
Circulation|May 17, 2021
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and MetoprololSiri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree, et al.
Translational Oncology|October 2, 2018
Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal CancerPaula A Bousquet, Sebastian Meltzer, Linda Sønstevold, et al.
Plos One|April 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitroMarion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares, et al.
Cancer Research and Treatment|August 5, 2016
Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic RadiotherapyErta Kalanxhi, Karianne Risberg, Imon S Barua, et al.
BMC Pediatrics|November 14, 2018
A retrospective study of neonatal case management and outcomes in rural Rwanda post implementation of a national neonatal care package for sick and small infantsMerab Nyishime, Ryan Borg, Willy Ingabire, et al.
Clinical Simulation in Nursing|March 21, 2022
A Multimodal Approach to Training Coronavirus Disease (COVID-19) Processes Across Four Intensive Care UnitsKatie M Moynihan, Dorothy M Beke, Annette Imprescia, et al.
European Heart Journal. Cardiovascular Imaging|November 7, 2017
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trialSiri Lagethon Heck, Geeta Gulati, Pavel Hoffmann, et al.
Pageof 18